InvestorsObserver
×
News Home

Is IDEXX Laboratories, Inc. (IDXX) Stock a Bad Value Wednesday?

Wednesday, March 20, 2024 03:19 PM | InvestorsObserver Analysts

Mentioned in this article

Is IDEXX Laboratories, Inc. (IDXX) Stock a Bad Value Wednesday?

A rating of 73 puts IDEXX Laboratories, Inc. (IDXX) near the top of the Healthcare sector according to InvestorsObserver. IDEXX Laboratories, Inc.'s score of 73 means that it ranks higher than 73% of stocks in the sector. In addition, its overall score of 78 ranks it higher than 78% of all stocks.

Overall Score - 78
IDXX has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on IDXX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With IDEXX Laboratories, Inc. Stock Today?

IDEXX Laboratories, Inc. (IDXX) stock has fallen -0.77% while the S&P 500 is up 0.79% as of 3:10 PM on Wednesday, Mar 20. IDXX has fallen -$4.12 from the previous closing price of $534.42 on volume of 246,047 shares. Over the past year the S&P 500 has gained 30.39% while IDXX is up 7.04%. IDXX earned $10.06 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 52.55. Click Here to get the full Stock Report for IDEXX Laboratories, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App